Miolo, G., Muraro, E., Caruso, D., Crivellari, D., Ash, A., Scalone, S., . . . Corona, G. (2016). Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer. Oncotarget.
Chicago-stil citatMiolo, Gianmaria, et al. "Pharmacometabolomics Study Identifies Circulating Spermidine and Tryptophan As Potential Biomarkers Associated With the Complete Pathological Response to Trastuzumab-paclitaxel Neoadjuvant Therapy in HER-2 Positive Breast Cancer." Oncotarget 2016.
MLA-referensMiolo, Gianmaria, et al. "Pharmacometabolomics Study Identifies Circulating Spermidine and Tryptophan As Potential Biomarkers Associated With the Complete Pathological Response to Trastuzumab-paclitaxel Neoadjuvant Therapy in HER-2 Positive Breast Cancer." Oncotarget 2016.